ephrins
Sign in to saveAlso known as IPR031328, Ephrin, ephrin, Ephrin receptor-binding domain, protein family, IPR001799, Eph receptor binding
Ephrins (also known as ephrin ligands or Eph family receptor interacting proteins) are a family of proteins that serve as the ligands of the Eph receptor. Eph receptors in turn compose the largest known subfamily of receptor protein-tyrosine kinases (RTKs).
Research
4,893 papers- Eph receptors and ephrins in cancer progression.Nature reviews. Cancer · 2024
- Ephrins and pain.Expert opinion on therapeutic targets · 2013
- Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis.Current rheumatology reports · 2019
- Ephs and Ephrins in Adult Endothelial Biology.International journal of molecular sciences · 2020
- Eph Receptors and Ephrins in Retinal Diseases.International journal of molecular sciences · 2021
via PubMed
~9 min read
Encyclopedic overview
8 sectionsContents
- Classification
- Function
- Axon guidance
- Retinotopic mapping
- Angiogenesis
- Migration factor in intestinal epithelial cell migration
- Reverse signaling
- References
Ephrins (also known as ephrin ligands or Eph family receptor interacting proteins) are a family of proteins that serve as the ligands of the Eph receptor. Eph receptors in turn compose the largest known subfamily of receptor protein-tyrosine kinases (RTKs).
Since ephrin ligands (ephrins) and Eph receptors (Ephs) are both membrane-bound proteins, binding and activation of Eph/ephrin intracellular signaling pathways can only occur via direct cell–cell interaction. Eph/ephrin signaling regulates a variety of biological processes during embryonic development including the guidance of axon growth cones, formation of tissue boundaries, cell migration, and segmentation. Additionally, Eph/ephrin signaling has been identified to play a critical role in the maintenance of several processes during adulthood including long-term potentiation, angiogenesis, and stem cell differentiation.
Excerpted from Wikipedia’s “ephrins” article, available under the CC BY-SA 4.0 licence.